Cell line · CVCL_0594
Papers264
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
1 to 20 of 264
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Directionally aligned nanofibrous polycaprolactone/gelatin scaffolds as durable scleral implants for long‐term ocular reconstruction | Bioeng Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
Exploring Chemical Diversity Alongside Antioxidant, Antimicrobial, Antiproliferative, Anti-Inflammatory, and Caenorhabditis elegans Locomotor Responses in Whole, Caps and Stipes of Suillus luteus and Agaricus bisporus. | Pharmaceuticals (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Fridericia chica standardized extract combined with tocotrienol-enriched fraction from Bixa orellana promotes gastric mucosal protection: in vitro combination selection and in vivo evaluation. | Pharm Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mechanism of activation of an ancestral TEC kinase by PIP3. | Npj Struct Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Aberrant Accumulation of Cyclin D1 Rewires Glutamine Metabolism and Generates a Metabolic Vulnerability in Squamous Cell Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| In Situ Genetic Engineering Facilitates MMP-9-Responsive TIMP1 Release Through Proteolytic Cleavage to Boost Diabetic Wound Healing. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf-1/ERK1/2/PINK1 Signaling Axis. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Antitumor-Relevant Evaluation of Liquid and Microencapsulated Lepidium meyenii and Bactris gasipaes Extracts Reveals Species- and Formulation-Dependent Activity. | Molecules | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MORC1 coordinates TRIM28 interaction and nuclear condensate formation for transposon silencing. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Paclitaxel induces NM2-dependent cellular contraction through GEF-H1 dissociation from microtubules and RhoA/ROCK activation in cancer cells. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer. | Mater Today Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Lentinan-Based Multifunctional Composite Hydrogel for Wound Healing. | Gels | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting circulating fatty acid-binding protein 4 ameliorates obesity-associated hepatic steatosis. | JHEP Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Fluorinated Chromone Derivatives: Synthesis, Theoretical Study, and Evaluation of Their Biological Potential. | ACS Omega | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multifunctional Near-Infrared-Responsive Silk Fibroin Nanomedicine for Tumor Treatment and Imaging. | Materials (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical evaluation of nitrated α-synuclein-specific CAR-Treg therapy in Parkinson's disease. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A C-Nucleoside Analogue of Cordycepin With High Metabolic Stability and Potent Anti-Psoriatic Activity via Microneedle Delivery. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Binding to Albumin and Off-Target Toxicity Confound the Use of LRRC8/VRAC Channel Blockers in Cell Physiology Assays. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| High-throughput ligand discovery in living cells using the cellular protein stability enhancement assay. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mucosal-associated invariant T cells recognize a tumor-derived metabolite in the DNA synthesis pathway. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0594/papers